501. Isavuconazole-induced Acute Liver Failure in a Pediatric Patient With Invasive Aspergillosis.
- Author
-
Brivio E, Verna M, Migliorino GM, Foresti S, Zucchini N, and Rovelli A
- Subjects
- Adolescent, Antifungal Agents administration & dosage, Bone Marrow Transplantation adverse effects, Humans, Male, Nitriles administration & dosage, Pyridines administration & dosage, Triazoles administration & dosage, Antifungal Agents adverse effects, Invasive Pulmonary Aspergillosis complications, Invasive Pulmonary Aspergillosis drug therapy, Liver Failure, Acute chemically induced, Liver Failure, Acute pathology, Nitriles adverse effects, Pyridines adverse effects, Triazoles adverse effects
- Abstract
Isavuconazole is a new azole approved for adults with invasive aspergillosis and mucormycosis, with a favorable hepatic tolerability reported in Phase III trials. Here, we report on a case of drug-induced liver failure related to isavuconazole in a pediatric patient treated for invasive aspergillosis after bone marrow transplant.
- Published
- 2019
- Full Text
- View/download PDF